Related Experiment Video
Updated: Nov 6, 2025
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
A case report of aggressive course of CD30+ primary cutaneous anaplastic large cell lymphoma
Wen-Tian Lyu1, Qi-Bin Song1, Wang Qiong2
1Department of Oncology, Huanggang Center Hospital, Huangzhou District, Huanggang.
Introduction:
CD30+ primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a rare T-cell neoplasm, and has been reported to present with an indolent behavior. The PC-ALCL with aggressive behavior has not been reported in the literature.
Patient Concerns:
We treated a patient with PC-ALCL that exhibited indolent behavior in the past 2 years and aggressive behavior within the last 3 months before presentation.
Diagnosis:
Aggressive CD30+ primary cutaneous anaplastic large cell lymphoma.
Interventions:
The radiotherapy regimen was individualized in terms of the target volume delineation and dose prescription, and the dose-response relationship was evaluated.
Outcomes:
The mean distance of microscopic infiltration was 14.1 mm in depth and 14.3 mm circumferentially. The lesion completely regressed after the delivery of 40 Gy in 20 fractions over 4 weeks. The tumor did not recur over the next year.
Conclusion:
An aggressive disease course is rare for indolent CD30+ PC-ALCL, which has similar histopathological characteristics as indolent PC-ALCL. The radiotherapy strategy should be individualized with curative intent.
